746
Participants
Start Date
February 1, 2022
Primary Completion Date
August 26, 2022
Study Completion Date
August 26, 2022
Dihydroartemisinin-Piperaquine
Treatment of females less than 10 years old and all males in Arm 2 and those who test positive in Arm 1.
Chloroquine
Treatment of females 10 years old and older in Arm 2 and those who test positive in Arm 1.
Kamuzu University of Health Sciences, Blantyre
Kamuzu University of Health Sciences
OTHER
Doris Duke Charitable Foundation
OTHER
University of Maryland, Baltimore
OTHER